GIC, hedge funds among anchor investors in Gland Pharma IPO

By Ankit Doshi

  • 07 Nov 2020
Premium
Credit: VCCircle

Drugmaker Gland Pharma Ltd, the first Indian company controlled by a Chinese firm to float an initial public offering, has raised Rs 1,943.86 crore ($262.68 million at current exchange rates) from anchor investors led by Singapore sovereign wealth fund GIC. Hyderabad-based Gland Pharma, which is majority-owned by China’s Shanghai Fosun Pharmaceutical ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.